ACAlejandra Curbelo-Paz

Alejandra Curbelo-Paz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alejandra Curbelo-Paz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Language, Culture, and Cancer: Qualitative Insights Into Communication Disparities Among Spanish‐Speaking Caregivers of Children With Cancer

    by Jenny Ruiz, Alejandra Curbelo‐Paz, Sonia Morales, Elizabeth Contreras, Amy Houtrow, Scott H. Maurer, Judy C. Chang

    Background: Latino children are projected to make up nearly one‐third of United States (US) children by 2060, and many of their caregivers speak Spanish. Prior survey research has documented communication difficulties for Spanish‐speaking caregivers of children with cancer, but contemporary qualitative data are limited. We sought to understand the communication experiences of Spanish‐speaking caregivers during a new childhood cancer diagnosis and elicit recommendations for improving family‐centered diagnostic communication. Methods: We conducted semi‐structured qualitative interviews in Spanish with adult Spanish‐speaking caregivers present during the initial oncology diagnosis conversation for a child diagnosed within the prior 10 years. Participants were recruited from two US pediatric centers using purposeful sampling. Bilingual interviewers conducted interviews from July 2024 to May 2025. Transcripts were analyzed using inductive qualitative content analysis by two independent bilingual coders, with iterative codebook development and constant comparison until thematic saturation. Results: Eleven mothers participated, all born outside the US; most children had hematologic malignancies. Five themes were identified as follows: (1) interpreter access and quality impacted understanding; (2) strong emotional responses to diagnosis, sometimes framed by cultural beliefs; (3) difficulty voicing concerns due to language differences; (4) experiencing connection when clinicians took time to communicate the diagnosis; and (5) recommendations, including more bilingual clinicians, in‐person professional interpreters, plain‐language explanations, and cultural humility training. Conclusions: Meaningful communication with Spanish‐speaking families at diagnosis requires systems‐level investment in qualified interpreters and bilingual clinicians, clinician behaviors that invite questions and validate emotion, and culturally responsive care.

  • Demographic characteristics and comorbidity associations in chronic hand eczema

    by Alejandra Curbelo-Paz, Christopher Guirguis, Joe K. Tung

  • Open Access

    Latest and Greatest in Inflammatory Skin Disease and Gut Microbiome

    by Alejandra Curbelo-Paz, Ellen T. Lee, Alana K. Sadur, Nicholas D’Angelo, Sonal Choudhary

    Emerging research highlights the complex interplay between the gut microbiome, skin health, and environmental exposures, forming what is now recognized as the gut–skin–exposome axis. This narrative review explores the role of gut microbiome dysbiosis—a disruption in the balance of intestinal microorganisms—in the pathogenesis and progression of various non-communicable inflammatory skin diseases, including acne, atopic dermatitis, psoriasis, rosacea, systemic lupus erythematosus, chronic spontaneous urticaria, hidradenitis suppurativa, and alopecia areata. This review synthesizes mechanistic studies, clinical trials, and Mendelian randomization data to elucidate how altered gut microbial composition contributes to systemic and cutaneous inflammation. Key modifiable factors, such as diet, antibiotics, stress, and sleep, as well as interventions like probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, are discussed for their potential therapeutic value. By integrating clinical insights with microbiome science, this review underscores the importance of a holistic, systems-based approach in managing inflammatory skin diseases, offering clinicians evidence-based strategies to improve patient outcomes through gut microbiome modulation.